SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-138257
Filing Date
2021-04-29
Accepted
2021-04-29 07:00:52
Documents
6
Period of Report
2021-06-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A d51526ddef14a.htm DEF 14A 388339
2 GRAPHIC g51526g01a20.jpg GRAPHIC 256096
3 GRAPHIC g51526g02a36.jpg GRAPHIC 158046
4 GRAPHIC g51526g21a56.jpg GRAPHIC 85119
5 GRAPHIC g51526g70x82.jpg GRAPHIC 24818
6 GRAPHIC g51526g88z98.jpg GRAPHIC 50972
  Complete submission text file 0001193125-21-138257.txt   1177789
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37813 | Film No.: 21867005
SIC: 2834 Pharmaceutical Preparations